An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo

Author:

Mayr Josef1234,Heffeter Petra56347,Groza Diana5634,Galvez Luis1834,Koellensperger Gunda1834,Roller Alexander1234,Alte Beatrix12345,Haider Melanie5634,Berger Walter56347,Kowol Christian R.12347ORCID,Keppler Bernhard K.12347

Affiliation:

1. University of Vienna

2. Institute of Inorganic Chemistry

3. Vienna

4. Austria

5. Institute of Cancer Research and Comprehensive Cancer Center

6. Medical University of Vienna

7. Research Platform “Translational Cancer Therapy Research”

8. Institute of Analytical Chemistry

Abstract

An oxaliplatin-based platinum(iv) drug which specifically binds to albumin after i.v. application led to several complete responses in tumor-bearing mice.

Funder

Austrian Science Fund

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Cited by 107 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3